TOKYO - Testing of fertilized eggs during in-vitro fertilization treatment to identify genetic diseases before pregnancy will be expanded to cover conditions that develop after adulthood, the Japan Society of Obstetrics and Gynecology said earlier this year, in a decision already questioned by one disabled group.
Sorry. This article is no longer available.
Sorry, this article was first published more than three months ago and is temporarily unavailable.
Once the upcoming introduction of a paid membership system is fully operational, paid members will have access to all our stories.
Free Membership Provides
Newsletter from Editorial Team and access to archive articles from past three months.
By continuing, you agree to the Terms of Use,
and Privacy Policy.
